This explains the sudden development of dyspnea and pulmonary edema in previously asymptomatic patients who experience atrial fibrillation with a rapid ventricular rate and the equally rapid improvement in these patients when the heart rate is slowed by means of cardiac glycosides and/or beta-adrenergic blocking agents, even when the cardiac output per minute reamins constant.